Editorial: Imaging and the treatment of crohn's perianal fistulas: To see is to believe

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 2987-2989

  Schwartz, David A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ANUS FISTULA; CLINICAL TRIAL; CROHN DISEASE; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; HEALING; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; REVIEW; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL FISTULA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERINEUM; THALIDOMIDE; TREATMENT OUTCOME;

EID: 72949085545     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.518     Document Type: Review

References (19)

1. Schwartz DA, Loft us EV Jr, Tremaine WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-880
2. Hellers G, Bergstrand O, Ewerth S et al. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980;21:525-527 (Pubitemid 10059414)
3. Present DH, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-1405 (Pubitemid 29205403)
4. Sands BE, Anderson FH, Bernstein CN et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:876-885
5. Colombel JF, Schwartz DA, Sandborn WJ et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009;58:940-948
6. Ng SC, Plamondon S, Gupta A et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am J Gastroenterol 2009;104:2973-2986 (this issue).
7. Rasul I, Wilson S, Cohen Z et al. Infliximab therapy for Crohn's disease fistulae: discordance between perianal ultrasound findings and clinical response. Gastroenterology 2001;120: A619.
8. Van Assche G, Vanbeckevoort D, Bielen D et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003;98:332-339
9. van Bodegraven AA, Sloots CE, Felt-Bersma RJ et al. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 2002;45:39-45;discussion 45-46
10. Schwartz DA, Wiersema MJ, Dudiak KM et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 2001;121:1064-1072
11. Beets-Tan RG, Beets GL, van der Hoop AG et al. Preoperative MR imaging of anal fistulas: does it really help the surgeon? Radiology 2001;218:75-84.
12. Ardizzone S, Maconi G, Colombo E et al. Perianal fistulae following infliximab treatment: clinical and endosonographic outcome. Inflamm Bowel Dis 2004;10:91-96
13. Schwartz DA, White CM, Wise PE et al. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas. Inflamm Bowel Dis 2005;11:727-732
14. Spradlin NM, Wise PE, Herline AJ et al. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. Am J Gastroenterol 2008;103:2527-2535
15. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503-1507
16. Caprilli R, Gassull MA, Escher JC et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55 (Suppl 1): i36-58.
17. Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 2007;56:453-455
18. Rutgeerts P, Diamond RH, Bala M et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63:433-42;quiz 464.
19. Froslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412-422